Chiusolo, Patrizia
 Distribuzione geografica
Continente #
EU - Europa 4299
NA - Nord America 4026
AS - Asia 1037
SA - Sud America 32
OC - Oceania 27
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9435
Nazione #
US - Stati Uniti d'America 3979
DE - Germania 1942
CN - Cina 801
SE - Svezia 785
IT - Italia 405
UA - Ucraina 382
GB - Regno Unito 242
FR - Francia 194
PL - Polonia 108
FI - Finlandia 91
IN - India 84
TR - Turchia 58
CA - Canada 42
AU - Australia 26
BE - Belgio 24
BR - Brasile 21
NL - Olanda 19
IR - Iran 16
VN - Vietnam 16
RU - Federazione Russa 14
AT - Austria 11
JP - Giappone 11
RO - Romania 11
ES - Italia 10
IE - Irlanda 10
ID - Indonesia 9
HU - Ungheria 8
SG - Singapore 7
GR - Grecia 6
IL - Israele 6
PT - Portogallo 6
CL - Cile 5
KR - Corea 5
NO - Norvegia 5
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
MY - Malesia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
PE - Perù 3
TH - Thailandia 3
BD - Bangladesh 2
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
HK - Hong Kong 2
IS - Islanda 2
MD - Moldavia 2
NP - Nepal 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 9435
Città #
Chandler 730
Jacksonville 294
Dearborn 243
San Mateo 226
Ashburn 192
Nanjing 178
Ann Arbor 169
Wilmington 155
Houston 150
Beijing 136
Nürnberg 114
Fairfield 113
Woodbridge 113
Boston 107
Warsaw 105
Redwood City 104
Lancaster 91
Cattolica 89
Seattle 86
Nanchang 84
Princeton 79
Bremen 71
Lawrence 68
Los Angeles 56
Milan 51
Redmond 51
Izmir 49
Munich 47
Kunming 46
Boardman 34
Tianjin 33
Norwalk 32
Cambridge 31
Shenyang 30
Shanghai 29
Guangzhou 27
Hangzhou 27
Leawood 27
Changsha 26
Hefei 26
Mountain View 25
Zhengzhou 24
Hebei 23
Auburn Hills 22
Brussels 22
Jiaxing 21
Rome 21
University Park 16
Augusta 15
Chicago 13
Hanoi 13
Toronto 13
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
London 10
San Diego 9
Simi Valley 8
Chengdu 7
Fuzhou 7
Jinan 7
New York 7
Phoenix 7
San Francisco 7
Andover 6
Buffalo 6
Ottawa 6
Columbus 5
Costa Mesa 5
Dublin 5
Helsinki 5
Menlo Park 5
Monmouth Junction 5
Mumbai 5
North Hollywood 5
San Jose 5
São Paulo 5
Vienna 5
Ardabil 4
Belize City 4
Berlin 4
Bologna 4
Kemerovo 4
Latham 4
Napoli 4
Ningbo 4
Padova 4
Seoul 4
Singapore 4
Taizhou 4
Albuquerque 3
Brescia 3
Chongqing 3
Como 3
Dong Ket 3
Frankfurt am Main 3
Garden City 3
Groningen 3
Hyderabad 3
Totale 4804
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 752
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 316
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 287
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 255
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 198
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 148
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 127
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 122
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 115
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 114
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 114
Correlation between paraproteinaemia and viral reactivation after allo-SCT 113
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 112
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 109
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 109
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 106
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 103
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 103
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 103
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 99
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 98
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 98
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 94
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 93
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 93
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 91
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 91
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 87
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 86
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 86
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 85
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 85
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 85
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 82
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 82
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 81
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 81
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 80
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 80
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 78
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 78
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 78
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 77
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 77
Hyperleukocytosis and leukostasis: management of a medical emergency 76
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 75
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 74
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 73
Neurologic improvement after peripheral blood stem cell transplantation in poems 72
Hyperleukocytosis and leukostasis: management of a medical emergency 72
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 70
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 70
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 69
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 68
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 67
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 66
Work related acute leukemia and mucor mycosis in a boat-builder 65
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 65
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 64
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 64
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 63
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 63
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 63
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 62
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 61
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 60
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 59
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 57
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 55
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 53
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 52
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 49
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 48
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 48
Changes in protein serum levels during stem cell transplantation 48
Unrelated cord blood transplantation and post-transplant cyclophosphamide 47
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 47
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 46
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 46
The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis. 45
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 44
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 44
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 43
Unrelated cord blood transplantation and post-transplant cyclophosphamide 41
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 41
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 40
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 39
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 39
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 39
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 39
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 38
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 38
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study 38
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer 37
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 37
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 37
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 37
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 37
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 36
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 36
Totale 8513
Categoria #
all - tutte 15580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018348 0000 035 2155 501053646
2018/20191154 59445267 209131 17473 667012683
2019/20202111 319175173147 203236 19996 122166156119
2020/20211242 811168196 111101 11432 1455826344
2021/20221531 146914265 10339 35218 88125260319
2022/20231794 433431239474 2170 00 0000
Totale 9677